Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC49H64N4O9 |
InChIKeyHPYUHRSGTVGEPH-JSFZGIFZSA-N |
CAS Registry2095244-97-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | JP | - | |
Neoplasms | Preclinical | JP | - |